Witryna11 kwi 2024 · Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry. OCALA, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and … WitrynaAIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research …

AIM ImmunoTech Inc. (AIM) Stock Price, News, Quote & History

Witryna12 kwi 2024 · AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, … WitrynaImmunotech' s securities had eight market makers and were eligible for the "piggyback" exception ofExchange Act Rule 15c2-11(f)(3). Immunotech Laboratories, Inc. 6. Immunotech, which formerly claimed to be developing media products for the marketing and entertainment industries under three different corporate names, entered into a phlegmonous dictionary

AIM ImmunoTech Inc.: AIM ImmunoTech Reports Fourth Quarter …

WitrynaAIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat ... WitrynaOCALA, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on … Witryna1 gru 2024 · About Enzolytics, Inc; Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins for the treatment of … phlegmonous edema